KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TherapeuticsMD (TXMD) Inventory (2016 - 2022)

TherapeuticsMD filings provide 13 years of Inventory readings, the most recent being $6.7 million for Q3 2022.

  • On a quarterly basis, Inventory fell 8.98% to $6.7 million in Q3 2022 year-over-year; TTM through Sep 2022 was $6.7 million, a 8.98% decrease, with the full-year FY2021 number at $7.6 million, down 4.64% from a year prior.
  • Inventory hit $6.7 million in Q3 2022 for TherapeuticsMD, up from $6.1 million in the prior quarter.
  • In the past five years, Inventory ranged from a high of $14.6 million in Q1 2020 to a low of $1.6 million in Q1 2018.
  • Median Inventory over the past 5 years was $7.5 million (2019), compared with a mean of $7.3 million.
  • Biggest five-year swings in Inventory: skyrocketed 342.89% in 2019 and later tumbled 49.71% in 2021.
  • TherapeuticsMD's Inventory stood at $3.3 million in 2018, then skyrocketed by 262.97% to $11.9 million in 2019, then crashed by 32.61% to $8.0 million in 2020, then fell by 4.64% to $7.6 million in 2021, then fell by 12.08% to $6.7 million in 2022.
  • The last three reported values for Inventory were $6.7 million (Q3 2022), $6.1 million (Q2 2022), and $9.0 million (Q1 2022) per Business Quant data.